Press Release
SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently,...
PreciseDX: Leading Hospital to Study Performance of the PreciseDx Breast Test as an Aid in the Treatment Decision Process NEW YORK, Nov. 29, 2022 /PRNewswire/ -- PreciseDx, a leading AI company leveraging the analysis of morphology...
Philips: Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency to address workforce shortages and staff burnout and enable a clear care pathway for every...
Tribun Health: In response to a call for tenders, Tribun Health had to undergo numerous evaluations and a rating system before joining the UniHA network in digital pathology. Paris, France, November 29th, 2022 – UniHA is a large...
EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)—Evident Corporation, a premier manufacturer of life...
Visiopharm today announces that it will be entering into a research pilot with Massachusetts General Hospital (MGH) to investigate the use of AI-powered precision pathology solutions for quality assurance of immunohistochemistry (IHC)...
